Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL
Cristina Sobacchi(Humanitas University), Miep Helfrich(University of Aberdeen), Matteo M. Guerrini(Fondazione Humanitas per la Ricerca), Annalisa Frattini(Institute of Genetic and Biomedical Research), Peter Grabowski(University of Sheffield), Robbert G. M. Bredius(Leiden University Medical Center), Chiara Messina(University of Insubria), Alessandra Pangrazio(Institute of Biomedical Technologies), Andrea Del Fattore(University of L'Aquila), Paolo Vezzoni(Institute of Genetic and Biomedical Research), Gabriella Errigo(University of Padua), Nick Bishop(University of Sheffield), Anna Villa(Institute of Genetic and Biomedical Research), Michael J. Rogers(Garvan Institute of Medical Research), Mario Abinun(North Tyneside General Hospital), Fraser P. Coxon(University of Aberdeen), Debbie I Scott(University of Aberdeen), Anna Teti(Instytut Biologii Doświadczalnej im. Marcelego Nenckiego), Andrew J. Cant(Clinical Research Institute), Grazia M.S. Mancini(Erasmus MC)
Cited by 387
Related Papers
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling
|Nature Genetics|2001|819
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
|Nature Genetics|2012|752
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
|The Journal of Experimental Medicine|2010|721
Osteopetrosis: genetics, treatment and new insights into osteoclast function
|Nature Reviews Endocrinology|2013|580